Find information on thousands of medical conditions and prescription drugs.

Lyme disease

Lyme disease or Lyme borreliosis is an infectious tick-borne disease, caused by the Borrelia spirochete, a gram-negative microorganism. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
Amyotrophic lateral...
Bardet-Biedl syndrome
Labyrinthitis
Lafora disease
Landau-Kleffner syndrome
Langer-Giedion syndrome
Laryngeal papillomatosis
Laryngomalacia
Lassa fever
LCHAD deficiency
Leber optic atrophy
Ledderhose disease
Legg-Calvé-Perthes syndrome
Legionellosis
Legionnaire's disease
Leiomyoma
Leiomyosarcoma
Leishmaniasis
Lemierre's syndrome
Lennox-Gastaut syndrome
Leprechaunism
Leprophobia
Leprosy
Leptospirosis
Lesch-Nyhan syndrome
Leukemia
Leukocyte adhesion...
Leukodystrophy
Leukomalacia
Leukoplakia
LGS
Li-Fraumeni syndrome
Lichen planus
Ligyrophobia
Limb-girdle muscular...
Limnophobia
Linonophobia
Lipodystrophy
Lipoid congenital adrenal...
Liposarcoma
Lissencephaly
Lissencephaly syndrome...
Listeriosis
Liticaphobia
Liver cirrhosis
Lobster hand
Locked-In syndrome
Loiasis
Long QT Syndrome
Long QT syndrome type 1
Long QT syndrome type 2
Long QT syndrome type 3
LSA
Lung cancer
Lupus erythematosus
Lyell's syndrome
Lygophobia
Lyme disease
Lymphangioleiomyomatosis
Lymphedema
Lymphoma
Lymphosarcoma
Lysinuric protein...
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Lyme disease is so named because it is generally believed to have first been observed in and around Old Lyme and Lyme, Connecticut in 1975. Before 1975, elements of Borrelia infection were also known as "tick-borne meningopolyneuritis", Garin-Bujadoux syndrome, Bannwarth syndrome or sheep tick fever. It is transmitted to humans by the bite of infected ticks.

History

The disease was first documented as a skin rash in Europe in 1883. Over the years, researchers there identified additional features of the disease, including an unidentified pathogen, its response to penicillin, the role of the Ixodes tick (wood tick) as its vector, and symptoms that included not only the rash but additional ones that affected the nervous system.

Researchers in the US had been aware of tick infections since the early 1900s. For example, an infection called tick relapsing fever was reported in 1905, and the wood tick, which carries an agent that causes Rocky Mountain spotted fever, was identified soon after. However, the full syndrome now known as Lyme disease, was not identified until a cluster of cases thought to be juvenile rheumatoid arthritis occurred in three towns in southeastern Connecticut, in the United States. Two of these towns, Lyme and Old Lyme, gave the disease its popular name.

In 1982 a novel spirochete was isolated and cultured from the midgut of Ixodes ticks, and subsequently from patients with Lyme disease. The infecting agent was first identified by Jorge Benach, and soon after isolated by Willy Burgdorfer, a scientist at the National Institutes of Health who specialized in the study of spirochete microorganisms. The spirochete was named Borrelia burgdorferi in his honor. Burgdorfer was the partner in the successful effort to culture the spirochete, along with Alan Barbour.

Microbiology

The disease is caused by the parasite Borrelia, which has well over three hundred known genomic strains but is usually cultured as Borrelia burgdorferi, Borrelia afzelii or Borellia garinii. Different Borrelia strains are predominant in Europe and North America.

The disease has been found to be transmitted to humans by the bite of infected Ixodes ticks. Not all ticks carry or can transmit this particular disease. The disease may also, in a few cases, be transmitted by mosquitoes, fleas or blackflies. However, other Borrelia strains (e.g. B. garinii) are probably transmitted this way.

Other tick-borne infections may be transmitted simultaneously with Lyme, including Bartonella, Babesiosis, Ehrlichiosis, and Rickettsia.

Borrelia burgdorferi resembles other spirochetes in that it is a highly specialized, motile, two-membrane, spiral-shaped bacterium which lives primarily as an extracellular pathogen. One of the most striking features of Borrelia burgdorferi as compared with other eubacteria is its unusual genome, which includes a linear chromosome approximately one megabase in size and numerous linear and circular plasmids.

Read more at Wikipedia.org


[List your site here Free!]


Identifying the vector of Lyme disease
From American Family Physician, 4/15/04 by Vincent Lo Re, III

Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. The vector that transmits B. burgdorferi is the deer tick (Ixodes scapularis), an inhabitant of the northeastern, southeastern, and north-central United States. (1) The deer tick also can transmit the agents of human babesiosis (Babesia microti) and ehrlichiosis (Ehrlichia chaffeensis, Ehrlichia phagocytophila, and Ehrlichia equi). (2)

Often, it is difficult to identify the important morphologic features of a tick (species, stage, and degree of engorgement) that are important in determining the risk of Lyme disease. Deer ticks have a four-stage life cycle: egg, larva, nymph, and adult. Figure 1 shows I. scapularis ticks at the nymph and adult stages, and an adult American dog tick (Dermacentor variabilis), which often is confused with the deer tick. Nymphal I. scapularis ticks (Figure 2a) transmit B. burgdorferi to humans far more frequently than adult ticks; ticks in the larva stage rarely are infected. (3) Laboratory studies have indicated that efficient transmission of this spirochete requires a minimum of 24 to 48 hours of tick attachment, at which time the nymph obviously is engorged with blood (Figure 2b). (4,5) B. burgdorferi is unlikely to infect a patient before the tick becomes engorged. D. variabilis ticks (Figure 1) are considerably larger than the I. scapularis nymph ticks and are not vectors of Lyme disease.

[FIGURES 1-2 OMITTED]

The most common sign of early Lyme disease is the hallmark rash, erythema migrans, which occurs in 80 percent of patients. (1) Erythema migrans is an intensely erythematous lesion surrounded by several concentric red rings (Figure 3), and often is accompanied by an influenza-like illness. (1) Other presenting symptoms include fatigue, myalgias, arthralgias, headache, fever, and chills. Cardiac manifestations (atrioventricular block and myocarditis) can be seen weeks to months after infection. Neurologic manifestations (aseptic meningitis, cranial neuropathy, and motor or sensory radiculoneuritis) and musculoskeletal findings (arthritis) may appear months to years later. (1)

[FIGURE 3 OMITTED]

The overall risk of acquiring Lyme disease from a deer tick bite is low, even in endemic areas. (6,7) In areas with a high incidence of Lyme disease, it may be reasonable to administer chemoprophylaxis with a single 200-mg oral dose of doxycycline (Vibramycin) to persons bitten by an I. scapularis nymph tick that is identified as being at least partially engorged with blood. (6,7) Persons who removed attached ticks within 24 hours should be observed. (1) Patients should be instructed to seek treatment if erythema migrans develops at the site of the bite. Treatment with doxycycline, 100 mg orally twice daily for 14 to 21 days, is recommended in persons who are at least eight years of age, except women who are pregnant. (1) For women who are pregnant and children less than eight years of age, amoxicillin, 500 mg orally three times daily for adults and 250 mg orally three times daily for children, should be administered for 14 to 21 days. A 14- to 21-day course of cefuroxime axetil (Ceftin), 500 mg orally twice daily in adults and 125 mg orally twice daily in children, is alternative therapy for those who may be allergic or unable to tolerate doxycycline or amoxicillin.

The authors indicate that they do not have any conflicts of interest. Sources of funding: none reported.

REFERENCES

(1.) Steere AC. Lyme disease. N Engl J Med 2001;345: 115-25.

(2.) Mylonakis E. When to suspect and how to monitor babesiosis. Am Fam Physician 2001;63:1969-74.

(3.) Matuschka FR, Spielman A. Risk of infection from and treatment of tick bite. Lancet 1993;342:529-30.

(4.) des Vignes F, Piesman J, Heffernan R, Schulze TL, Stafford KC 3d, Fish D, et al. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001;183:773-8.

(5.) Sood SK, Salzman MB, Johnson BJ, Happ CM, Feig K, Carmody L, et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis 1997; 175:996-9.

(6.) Shapiro ED. Doxycycline for tick bites-not for everyone [Editorial]. N Engl J Med 2001;345:133-4.

(7.) Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.

VINCENT LO RE III, M.D., University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

JAMES L. OCCI, M.S., Rutgers University, Newark, New Jersey

ROB ROY MACGREGOR, M.D., University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

VINCENT LO RE III, M.D., is a postdoctoral research fellow in the Division of Infectious Diseases at the University of Pennsylvania School of Medicine, Philadelphia, where he received his medical degree. Dr. Lo Re completed a residency in internal medicine and an infectious diseases fellowship at the Hospital of the University of Pennsylvania, where he was chief resident.

JAMES L. OCCI, M.S., currently is enrolled in a master's degree program in biology at Rutgers University, Newark, N.J. He received his undergraduate degree from Montclair State College, Montclair, N.J., and his Master of Science degrees in biology from Montclair State College and microbiology from Seton Hall University, Newark, N.J.

ROB ROY MACGREGOR, M.D., is professor of infectious diseases and director of HIV programs and clinical research at the Hospital of the University of Pennsylvania School of Medicine. He received his medical degree from Harvard Medical School, Boston, and completed a fellowship in infectious diseases at the University of Washington School of Medicine, Seattle.

Address correspondence to Vincent Lo Re III, M.D., Division of Infectious Diseases, University of Pennsylvania School of Medicine, 502 Johnson Pavilion, Philadelphia, PA 19104 (e-mail: vincent.lore@uphs.upenn.edu). Reprints are not available from the authors.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Lyme disease
Home Contact Resources Exchange Links ebay